Managlay, Merry-an .
HRN: 07-90-25 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/28/2025
CEFTRIAXONE 1G (VIAL)
09/28/2025
10/05/2025
IV
2g
OD
T/c H Mole; T/c CAP-MR
Checking Initial Appropriateness
09/29/2025
MUPIROCIN 2%, 15G (TUBE)
09/29/2025
10/06/2025
SKIN
2%
BID
Lesions On Skin
Checking Final Appropriateness